Dear VESL members,

It is my pleasure to announce that VESL is now a multi-sponsored community of practice made possible with the financial support of Novartis Canada, Novo Nordisk Canada, and HLS Therapeutics.

We’d like to extend special thanks to Novartis Canada for its critical role as the founding and sole sponsor of VESL for the past 4 years, and for its vision and generosity in supporting VESL’s transition to this new multi-sponsorship model.

Rest assured that the format of VESL will remain the same and that members of the community can expect to continue to receive updates about publications, conference updates, and interviews with leaders in the field.

We’re delighted that VESL will continue to support Canadian healthcare professionals to collaborate and enhance understanding around emerging therapies in atherosclerotic cardiovascular disease. See VESL member publications, news and resources at app.sosido.com/communities/vesl.

Thank you to our sponsors!

Best Regards,

Paul Abbass
VESL Community Manager
LegitiMed Inc.